BUDESONIDE
NDC 45802-627, budesonide, aerosol, foam, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-627
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- AEROSOL, FOAM
- Route
- RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215328
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-627 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUDESONIDE2 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-627-86 | 45802062786 | 2 CANISTER in 1 CARTON (45802-627-86) / 1 AEROSOL, FOAM in 1 CANISTER (45802-627-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ad4a68e7-9200-4f05-8058-714d5d8900f8NADAC price for package 45802062786
GET /v1/drugs/nadac/45802062786
Use it
Look up 45802-627 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-627 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-627. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.